A share price of Pulmonx Corp [LUNG] is currently trading at $3.18, up 0.95%. An important factor to consider is whether the stock is rising or falling in short-term value. The LUNG shares have gain 18.66% over the last week, with a monthly amount glided 15.64%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pulmonx Corp [NASDAQ: LUNG] stock has seen the most recent analyst activity on March 10, 2025, when D. Boral Capital initiated its Buy rating and assigned the stock a price target of $17. Previously, Citigroup downgraded its rating to Neutral on December 11, 2024, and dropped its price target to $7.50. On June 04, 2024, Lake Street initiated with a Buy rating and assigned a price target of $12 on the stock. Wells Fargo downgraded its rating to a Equal Weight and decreased its price target to $14 on February 23, 2024. Craig Hallum initiated its recommendation with a Buy and recommended $18 as its price target on September 05, 2023. Wells Fargo upgraded its rating to Overweight for this stock on February 27, 2023, and upped its price target to $15. In a note dated January 03, 2023, BofA Securities downgraded an Underperform rating on this stock but restated the target price of $8.
Pulmonx Corp experienced fluctuations in its stock price throughout the past year between $2.50 and $9.37. Currently, Wall Street analysts expect the stock to reach $11.93 within the next 12 months. Pulmonx Corp [NASDAQ: LUNG] shares were valued at $3.18 at the most recent close of the market. An investor can expect a potential return of 275.16% based on the average LUNG price forecast.
Analyzing the LUNG fundamentals
Trailing Twelve Months sales for Pulmonx Corp [NASDAQ:LUNG] were 87.47M which represents 19.54% growth. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at -0.66%, Pretax Profit Margin comes in at -0.65%, and Net Profit Margin reading is -0.65%. To continue investigating profitability, this company’s Return on Assets is posted at -0.38, Equity is -0.64 and Total Capital is -0.46. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.73.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Pulmonx Corp [NASDAQ:LUNG] is 4.97. On the other hand, the Quick Ratio is 4.29, and the Cash Ratio is 2.99. Considering the valuation of this stock, the price to sales ratio is 1.46, the price to book ratio is 1.65.
Transactions by insiders
Recent insider trading involved Ferrari Richard, Director, that happened on Jun 12 ’25 when 8000.0 shares were sold. Director, Ferrari Richard completed a deal on Jun 13 ’25 to buy 5438.0 shares. Meanwhile, Director RICH FERRARI bought 8000.0 shares on Jun 12 ’25.
